(Q35112016)

6 August 2017

1 reference

title

Human immunodeficiency virus-associated dementia: an evolving disease (English)

1 reference

6 August 2017

0 references

Ned Sacktor

1 reference

6 August 2017

Justin C McArthur

1 reference

6 August 2017

Norman Haughey

1 reference

6 August 2017

Suzanne Gartner

1 reference

6 August 2017

Kathy Conant

1 reference

6 August 2017

Carlos Pardo

1 reference

6 August 2017

Avi Nath

1 reference

6 August 2017

publication date

1 April 2003

1 reference

6 August 2017

published in

Journal of NeuroVirology

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

205-221

1 reference

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

6 August 2017

cites work

1 reference

12 December 2020

Variable progression of HIV-associated dementia

1 reference

12 December 2020

Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis

1 reference

12 December 2020

Bacterial and fungal brain infections in AIDS.

1 reference

12 December 2020

Prospects for therapy of HIV-associated neurologic diseases

1 reference

12 December 2020

PCR detection of HIV proviral DNA in the brain of an asymptomatic HIV-positive patient

1 reference

12 December 2020

Correlation between viral load measurements and outcome in clinical trials of antiviral drugs.

1 reference

12 December 2020

Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis

1 reference

12 December 2020

Targeting neurotherapeutic agents through the blood-brain barrier

1 reference

12 December 2020

Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

1 reference

12 December 2020

Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study.

1 reference

12 December 2020

The passage of azidodeoxythymidine into and within the central nervous system: does it follow the parent compound, thymidine?

1 reference

12 December 2020

Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia

1 reference

12 December 2020

Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy.

1 reference

12 December 2020

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

1 reference

12 December 2020

Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy

1 reference

12 December 2020

Clinical-neuropathologic correlation in HIV-associated dementia

1 reference

12 December 2020

Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis

1 reference

12 December 2020

Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia

1 reference

12 December 2020

Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease

1 reference

12 December 2020

HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy

1 reference

12 December 2020

Unique monocyte subset in patients with AIDS dementia

1 reference

12 December 2020

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

1 reference

12 December 2020

Nigral degeneration in acquired immune deficiency syndrome (AIDS)

1 reference

12 December 2020

High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients

1 reference

12 December 2020

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

1 reference

12 December 2020

Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexus

1 reference

12 December 2020

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

1 reference

12 December 2020

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

12 December 2020

Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients

1 reference

12 December 2020

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals

1 reference

12 December 2020

Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

12 December 2020

Efavirenz-induced catatonia

1 reference

12 December 2020

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy

1 reference

12 December 2020

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

1 reference

12 December 2020

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

12 December 2020

Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study

1 reference

12 December 2020

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

1 reference

12 December 2020

Progression of HIV-associated dementia treated with HAART.

1 reference

12 December 2020

Cerebellar degeneration associated with human immunodeficiency virus infection

1 reference

12 December 2020

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria

1 reference

12 December 2020

AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987–93) and differential incidence according to mode of transmission of HIV-1 infection

1 reference

12 December 2020

Through a glass, darkly: cerebrospinal fluid viral load measurements and the pathogenesis of human immunodeficiency virus infection of the central nervous system

1 reference

12 December 2020

Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain

1 reference

12 December 2020

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

1 reference

12 December 2020

Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects.

1 reference

12 December 2020

Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.

1 reference

12 December 2020

Parkinsonism with HIV infection

1 reference

12 December 2020

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients

1 reference

12 December 2020

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

1 reference

12 December 2020

HTLV-III infection in brains of children and adults with AIDS encephalopathy

1 reference

12 December 2020

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

1 reference

12 December 2020

Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain

1 reference

12 December 2020

Neurological and neuropshychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection

1 reference

12 December 2020

Cytokines in the brain during viral infection: clues to HIV-associated dementia

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

The entry of antiviral and antiretroviral drugs into the central nervous system.

1 reference

12 December 2020

Neurologic manifestations of AIDS.

1 reference

12 December 2020

AIDS epidemic update: December 1999.

1 reference

12 December 2020

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

1 reference

12 December 2020

Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.

1 reference

12 December 2020

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters

1 reference

12 December 2020

Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment

1 reference

12 December 2020

Follicular dendritic cell contributions to HIV pathogenesis

1 reference

12 December 2020

Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation

1 reference

12 December 2020

The AIDS dementia complex: I. Clinical features

1 reference

12 December 2020

Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging

1 reference

12 December 2020

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

12 December 2020

Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings

1 reference

12 December 2020

Alzheimer's disease: genetic studies and transgenic models

1 reference

12 December 2020

Cerebrospinal fluid response to structured treatment interruption after virological failure.

1 reference

12 December 2020

Metabolic characterization of neurological diseases by proton localized NMR spectroscopy of the human brain

1 reference

12 December 2020

Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Neuropathology of human immunodeficiency virus infection at different disease stages

1 reference

12 December 2020

Randomized Double-blind Placebo-Controlled Trial of Peptide T for HIV-Associated Cognitive Impairment

1 reference

12 December 2020

Detection of HIV proviral DNA in cortex and white matter of AIDS brains by non-isotopic polymerase chain reaction: correlation with diffuse poliodystrophy

1 reference

12 December 2020

Redistribution of HIV outside the lymphoid system with onset of AIDS.

1 reference

12 December 2020

Multiple sclerosis-like illness occurring with human immunodeficiency virus infection

1 reference

12 December 2020

A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment

1 reference

12 December 2020

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

12 December 2020

HIV infection and dementia

1 reference

12 December 2020

AIDS dementia complex: evaluation with proton MR spectroscopic imaging

1 reference

12 December 2020

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

1 reference

12 December 2020

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

1 reference

12 December 2020

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

1 reference

12 December 2020

In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues

1 reference

12 December 2020

Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy

1 reference

12 December 2020

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

1 reference

12 December 2020

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

1 reference

12 December 2020

A phase I/II trial of nimodipine for HIV-related neurologic complications.

1 reference

12 December 2020

Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment

1 reference

12 December 2020

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

12 December 2020

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

1 reference

12 December 2020

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020

Diffusion tensor imaging in HIV infection: what is it telling us?

1 reference

12 December 2020

Genotypic-resistance assays and antiretroviral therapy

1 reference

12 December 2020

The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group

1 reference

12 December 2020

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

1 reference

12 December 2020

Getting to the HAART of T cell dynamics

1 reference

12 December 2020

Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex

1 reference

12 December 2020

Increased frequency of the tumor necrosis factor-alpha-308 A allele in adults with human immunodeficiency virus dementia

1 reference

12 December 2020

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

1 reference

12 December 2020

AIDS dementia complex with generalized myoclonus

1 reference

12 December 2020

AIDS — The First 20 Years

1 reference

12 December 2020

Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors

1 reference

12 December 2020

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

12 December 2020

Evaluation of the AIDS dementia complex in clinical trials

1 reference

12 December 2020

Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy

1 reference

12 December 2020

Clinical trials in HIV-associated cognitive impairment: Cognitive and functional outcomes

1 reference

12 December 2020

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

12 December 2020

Insights into the role of immune activation in HIV neuropathogenesis

1 reference

12 December 2020

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

1 reference

12 December 2020

CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing

1 reference

12 December 2020

Localized cerebral proton MR spectroscopy in HIV infection and AIDS.

1 reference

12 December 2020

High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis.

1 reference

12 December 2020

Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS

1 reference

12 December 2020

Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

The neurobiology of human immunodeficiency virus infections

1 reference

12 December 2020

Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS)

1 reference

12 December 2020

Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea

1 reference

12 December 2020

Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

1 reference

12 December 2020

Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia

1 reference

12 December 2020

Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders

1 reference

12 December 2020

Epidemiology of human immunodeficiency virus encephalopathy in the United States

1 reference

12 December 2020

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

1 reference

12 December 2020

Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels

1 reference

12 December 2020

Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance

1 reference

12 December 2020

Proton MR Spectroscopy of the Brain in AIDS Dementia Complex

1 reference

12 December 2020

HIV in the brain: RNA levels and patterns of zidovudine resistance

1 reference

12 December 2020

Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia

1 reference

12 December 2020

Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment

1 reference

12 December 2020

Differences among HIV-1 variants in their ability to elicit secretion of TNF-alpha

1 reference

12 December 2020

10.1080/13550280390194109

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1052280988

0 references

1 reference